Cargando…
Protein interactome of the Cancerous Inhibitor of protein phosphatase 2A (CIP2A) in Th17 cells
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is involved in immune response, cancer progression, and Alzheimer's disease. However, an understanding of the mechanistic basis of its function in this wide spectrum of physiological and pathological processes is limited due to its poorly ch...
Autores principales: | Khan, Mohd Moin, Välikangas, Tommi, Khan, Meraj Hasan, Moulder, Robert, Ullah, Ubaid, Bhosale, Santosh Dilip, Komsi, Elina, Butt, Umar, Qiao, Xi, Westermarck, Jukka, Elo, Laura L., Lahesmaa, Riitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008788/ https://www.ncbi.nlm.nih.gov/pubmed/33817627 http://dx.doi.org/10.1016/j.crimmu.2020.02.001 |
Ejemplares similares
-
CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling
por: Khan, Mohd Moin, et al.
Publicado: (2020) -
Quantitative Proteomics Reveals the Dynamic Protein Landscape during Initiation of Human Th17 Cell Polarization
por: Tripathi, Subhash K., et al.
Publicado: (2018) -
PP2A and Its Inhibitors in Helper T-Cell Differentiation and Autoimmunity
por: Khan, Mohd Moin, et al.
Publicado: (2022) -
Long Intergenic Noncoding RNA MIAT as a Regulator of Human Th17 Cell Differentiation
por: Khan, Mohd Moin, et al.
Publicado: (2022) -
The L1TD1 Protein Interactome Reveals the Importance of Post-transcriptional Regulation in Human Pluripotency
por: Emani, Maheswara Reddy, et al.
Publicado: (2015)